WHO recommends Veklury for high-risk patients
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
Read More
Tag: Veklury
Gilead’s Veklury should be effective against COVID-19 variants
Company has completed genetic analysis for UK and South African variants
Read More
Gilead’s COVID-19 drug remdesivir bags US approval
Antiviral becomes first COVID-19 treatment approved in the US
Read More
Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
Read More
CHMP backs approval of remdesivir as COVID-19 treatment
The drug is the first to be recommended as a treatment for the virus in the EU
Read More
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
